Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Erlotinib/gefitinib

Dermatological effects: 2 case reports

    • 14 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Ong CK, Tan WC, Chan LC, Abdul Razak M.Cutaneous side-effects of epidermal growth factor receptor-tyrosine kinase inhibitor (TKI) in the treatment of lung cancer: description and its management. Medical Journal of Malaysia 67: 222-3, No. 2, Apr 2012 - Malaysia

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Erlotinib/gefitinib. React. Wkly. 1429, 18 (2012). https://doi.org/10.2165/00128415-201214290-00062

    Download citation

    Keywords

    • Gefitinib
    • Erlotinib
    • Doxycycline
    • Benzoyl Peroxide
    • Paronychia